We are proud to share that Aisthesis Medical has won the Partnership with the NHS Award at the 2026 SEHTA Healthcare Business Awards, held on 26th May at Scale Space, Imperial College London. We were also recognised as Runner-up in the Advances in Digital Healthcare category — two recognitions that reflect the clinical rigour, NHS integration, and technical innovation at the heart of VIOSync®.
The SEHTA Healthcare Business Awards celebrate the leading health technology companies across South East England, London, Oxford, East of England, and Essex — bringing together NHS trusts, academic institutions, investors, and industry leaders to recognise excellence across the innovation lifecycle.
The Results
🏆 Winner — Partnership with the NHS Award
Recognises meaningful collaborations between industry and NHS organisations that enhance service delivery, improve patient outcomes, or create innovative care pathways. Awarded to companies demonstrating NHS engagement, deployment readiness, and measurable clinical impact.
🥈 Runner-up — Advances in Digital Healthcare Award
Evaluates how digital technologies enhance service delivery or create new ways of delivering healthcare, assessed on technologies employed, deployment partnerships, and improvements to patient care.
What Winning the NHS Partnership Award Means
For a pre-market clinical AI company on the CE MDR pathway, recognition in the NHS Partnership category carries particular weight. Clinical AI platforms frequently struggle with the gap between technical development and healthcare system integration — impressive models that cannot deploy because they have not engaged with the realities of NHS workflows, data infrastructure, procurement pathways, or clinical adoption.
This award validates that Aisthesis Medical is building VIOSync® with NHS deployment in mind from the outset, not as an afterthought once the technology is “finished”. It reflects our work to understand clinical workflows, engage NHS stakeholders on validation requirements, and design for integration with the hospital systems that frontline teams already use every day.
Winning this category — from a record field of entries in 2026 — signals that the judging panel sees VIOSync® not only as technically capable, but as a platform that the NHS can realistically adopt.
“Another record-breaking year for entries — and to see the depth of achievement by them all was inspiring. Congratulations to all the winners, runner-ups, and finalists.”
Neil Roberts, Managing Director, SEHTA
Next Stop: Medilink UK National Healthcare Business Awards
As a category winner at the SEHTA awards, Aisthesis Medical has been entered for shortlisting at the Medilink UK National Healthcare Business Awards, taking place on 9th July 2026 at Pioneer Group, Victoria House, London.
The Medilink UK awards represent national-level recognition across the UK health technology ecosystem — the next stage of visibility for companies that have demonstrated regional excellence through SEHTA. We’re proud to carry that momentum forward.
VIOSync®: Earlier Recognition, Safer Responses
VIOSync® is our hospital-grade clinical AI platform for early sepsis detection and acute deterioration management. Retrospective validation studies suggest the potential to support clinical teams in identifying risk significantly earlier than traditional methods — designed from day one for frontline NHS environments.
- Predictive Intelligence: Retrospective studies suggest the potential for sepsis risk prediction up to 48 hours in advance, depending on setting and data availability.
- Explainable AI (XAI): Transparent outputs designed to support clinician trust, validation, and regulatory auditability — not a black box.
- Workflow Integration: Evidence-based guidance embedded directly into clinical workflows, reducing friction at the bedside, not adding to it.
- Multimodal Data Fusion: Integrates vital signs, lab results, and clinical context using Digital Patient Twin architecture.
- Regulatory Credibility: CE MDR technical documentation in progress, underpinned by ISO 13485, NHS DSPT ‘Standards Exceeded’, and Cyber Essentials Plus certification.
About the 2026 SEHTA Healthcare Business Awards
The Science and Engineering Health Technologies Alliance (SEHTA) awards are the leading regional celebration of collaboration between industry, academia, and the NHS. The awards cover one of the UK’s most innovation-dense healthcare regions, spanning Kent, Surrey, Sussex, Hampshire, Isle of Wight, London, Oxford, East of England, and Essex.
The 2026 edition saw a record-breaking number of entries across all categories. Winners are automatically entered for shortlisting at the Medilink UK National Healthcare Business Awards, creating a clear pathway from regional recognition to national visibility.
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven digital patient twin platform that goes beyond early sepsis prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.
Want to Learn More or Partner With Us?
If you’re a hospital, NHS trust, or healthcare investor interested in learning more about VIOSync or our security and compliance posture, we’d love to connect.
📩 Get in touch: https://aisthesismed.com/contact/
🌐 Learn more about VIOSync: https://aisthesismed.com/product/